Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.
There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a...
Главные авторы: | Genki Hayashi, Gino Cortopassi |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Public Library of Science (PLoS)
2016-01-01
|
Серии: | PLoS ONE |
Online-ссылка: | http://europepmc.org/articles/PMC4831832?pdf=render |
Схожие документы
-
Sexual dimorphism in a mouse model of Friedreich’s ataxia with severe cardiomyopathy
по: Lili Salinas, и др.
Опубликовано: (2024-10-01) -
Potential biomarker identification for Friedreich's ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion.
по: Marissa Z McMackin, и др.
Опубликовано: (2019-01-01) -
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
по: Mittal Jasoliya, и др.
Опубликовано: (2019-01-01) -
Genetics and Friedreich Ataxia
по: J Gordon Millichap
Опубликовано: (2002-06-01) -
Genetics of Friedreich Ataxia
по: J Gordon Millichap
Опубликовано: (1997-06-01)